Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Generation and Validation of Triple Negative Breast Cancer BioID Cell Lines to Define the FASN Interactome

EF 2025-26

Résumé
Fatty acid synthase (FASN) is a multifunctional metabolic enzyme that drives fatty acid biosynthesis and plays a critical role in the growth and metastasis of a variety of cancers. Of these subtypes affected by the expression and function of FASN is triple-negative breast cancer (TNBC), which is a heterogeneous breast cancer subtype characterized by unfavorable prognoses due to insufficient targeted therapies. While FASN’s enzymatic function is well established in normal and disease contexts, recent studies have pointed to functions that are independent of its lipid synthesis activity and contribute to the regulation of signaling pathways related to tumor cell development and proliferation. The non-canonical functions of this enzyme bypass the action of existing FASN inhibitors, which directly target its fatty acid biosynthesis activity, thus rendering these compounds less effective in blocking cancer progression and inducing tumor cell death. We hypothesize that the non-canonical contributions of FASN to cancer development are mediated by direct interactions with signaling pathway components, yet the protein interaction network of FASN within cancer cells remains poorly understood. This project aims to identify and validate FASN interactions in TNBC cell lines, which will allow for the characterization of distinct signaling networks of FASN in this disease. These results will serve as a foundation for future studies investigating FASN-mediated signaling pathways in cancer, which can influence the development of therapies that simultaneously target FASN’s enzymatic and non-catalytic functions.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573019
Name
Quadri Elise M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Generation and Validation of Triple Negative Breast Cancer BioID Cell Lines to Define the FASN Interactome
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cancer Signaling Pathways; Cell Signal Transduction; Fatty Acid Synthase; Immunoprecipitation; Non-Canonical Enzyme Activity; Protein Interaction Networks; Proximity Ligation Assay; Proximity-Dependent Biotin Identification Assay; Triple Negative Breast Cancer
Abstract
Fatty acid synthase (FASN) is a multifunctional metabolic enzyme that drives fatty acid biosynthesis and plays a critical role in the growth and metastasis of a variety of cancers. Of these subtypes affected by the expression and function of FASN is triple-negative breast cancer (TNBC), which is a heterogeneous breast cancer subtype characterized by unfavorable prognoses due to insufficient targeted therapies. While FASN’s enzymatic function is well established in normal and disease contexts, recent studies have pointed to functions that are independent of its lipid synthesis activity and contribute to the regulation of signaling pathways related to tumor cell development and proliferation. The non-canonical functions of this enzyme bypass the action of existing FASN inhibitors, which directly target its fatty acid biosynthesis activity, thus rendering these compounds less effective in blocking cancer progression and inducing tumor cell death. We hypothesize that the non-canonical contributions of FASN to cancer development are mediated by direct interactions with signaling pathway components, yet the protein interaction network of FASN within cancer cells remains poorly understood. This project aims to identify and validate FASN interactions in TNBC cell lines, which will allow for the characterization of distinct signaling networks of FASN in this disease. These results will serve as a foundation for future studies investigating FASN-mediated signaling pathways in cancer, which can influence the development of therapies that simultaneously target FASN’s enzymatic and non-catalytic functions.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Quadri, Elise M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~